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Background: Alterations in hematology, especially erythroid changes, may be involved in acute mountain sickness
(AMS) at high altitude. This study aimed to identify the relationship between excessive erythrocytosis and AMS
following different durations of high-altitude exposure.
Methods: A total of 692 healthy young Chinese men were recruited for the study in June and July of 2012 and
were divided into the following five groups: I) the 24-h group (24 hours after arrival at Lhasa, 3,700 m, n = 261); II)
the 7-d group (exposed at Lhasa, 3,700 m for seven days, n = 99); III) the re-exposure group (re-exposed at Yang
Bajing, 4,400 m for seven days after >1 year of acclimation at 3,700 m,n = 94); IV) the acclimated group (>1 year of
acclimation at 3,700 m, Lhasa, n = 42); and V) the sea-level control (control group, Chengdu, n = 196). Case report
forms were used to record the subjects’ demographic information and AMS-related symptoms. All of the subjects
underwent routine blood tests.
Results: The red blood cell (RBC) count fell slightly but was not significant upon acute exposure to high altitude,
whereas the hemoglobin concentration ([Hb]) increased significantly. After high-altitude re-exposure, both of the
[Hb] and RBC count showed significant increases. The incidence of AMS was 65.1%, 26.3% and 51.1%, respectively
in the 24-h, 7-d and re-exposure groups. The [Hb] (P = 0.024) and hematocrit (P = 0.017) were greater in the AMS+
individuals than in the AMS− individuals in 7-d group. A correlation analysis revealed that the [Hb] and hematocrit
were closely related with AMS score in 7-d and re-exposure groups, while the RBC showed a correlation with AMS
score only in the re-exposure group. The AMS incidence was lowest when the [Hb] was between 140 and 160 g/L
in the 24-h and 7-d groups.
Conclusions: AMS is associated with both [Hb] and excessive erythrocytosis. Additionally, our findings indicate the
existence of an optimal [Hb] for preventing AMS.
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The hematological system is responsible for the delivery
of oxygen and energy as well as the removal of carbon di-
oxide and the metabolic wastes that have been modified
in high altitude hypoxia stress during migrations and
among natives of high altitude [1-4]. Excessive erythrocy-
tosis includes increases in the hemoglobin (Hb) and red
blood cells (RBC) in the hematological system. The roles
of the primary component Hb, in the combination, stor-
age, transport and release of oxygen are of such critical
importance that its alteration may be involved in the* Correspondence: huanglan260@126.com
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unless otherwise stated.pathogenesis of AMS in a brief period of time and in accli-
mation over a longer duration [5,6]. Additionally, modifi-
cations of other parameters and components, such as the
RBC, hematocrit (HCT), mean cell volume (MCV), mean
corpuscular hemoglobin (MCH) and mean corpuscular
hemoglobin concentration (MCHC) in blood, have also
been considered to play key roles in the pathophysio-
logical processes in high altitude environments [7].
However, if adaption fails to compensate after arrival at
high altitude, a series of symptoms or even acute moun-
tain sickness (AMS) appears. AMS has been considered to
be a type of dysfunction of adaption for high altitude that
occurs in individuals who have recently arrived at an alti-
tude > 2,500 m [8,9]. Although it has been studied ford. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Demographic information for each group
Group Age (year) BMI (kg/m2)
Sea-level (n = 196) 22.23 ± 2.41 21.37 ± 2.44
24-h group (n = 261) 22.83 ± 3.65 21.49 ± 2.32
7-d group (n = 99) 22.55 ± 3.67 21.52 ± 2.07
Acclimated group (n = 42) 24.57 ± 4.81 22.06 ± 2.53
Re-exposure group (n = 94) 23.01 ± 2.93 21.08 ± 1.96
F value 1.773 0.843
P value 0.151 0.471
The ages and BMIs in the five groups were matched.
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have not been fully understood [9,10]. It is known that the
hypoxic vasoconstriction and vasodilatation responses are
involved in the pathophysiological processes of AMS,
however, the hematological alterations have been thought
to participate in the pathogenesis of AMS, perhaps due to
the delivery of oxygen in the blood flow [11].
The numerous previous studies focused on the
hematological alterations in long-term transmigrations,
whereas there is scant research on excessive erythrocyto-
sis, especially on Hb, HCT and RBC in short-term
exposure to hypoxia and in re-exposure to greater hyp-
oxia and their relationships with AMS [4,11]. Thus, we
postulate that the excessive erythrocytosis that occurs
during various high-altitude exposure durations are cor-
related closely with AMS. Therefore, this present study
was performed to explore the roles of excessive erythro-
cytosis in the pathogenesis of AMS by focusing on the
hematological components that relate to the delivery of
oxygen, including Hb concentration ([Hb]), RBC, HCT,
MCV, MCH and MCHC.
Methods
Participants and procedures
The subjects (n = 692) were recruited in June and July of
2012 in Chengdu and Lhasa according to the inclusion
and exclusion criteria. The inclusion criteria were as fol-
lows: healthy males between 18 and 60 years old. The ex-
clusion criteria were people with any of the following
conditions: respiratory system diseases, cardiovascular sys-
tem diseases, neuropsychosis, cerebrovascular diseases,
malignant tumors or dysfunctions of the liver or the kid-
neys. The volunteers were divided into five groups: the
acute high-altitude exposure group who ascended to
3,700 m from 500 m in two hours by plane (24-h group,
n = 261), the 7-d group who was exposed at 4,400 m for
7 days (n = 99), the acclimated group who had been accli-
mated at 3700 m for more than 1 year (n = 42) and the re-
exposure group who had immigrated to 3,700 m for >
1 year and ascended to a higher altitude of 4,400 m for
seven days (n = 94). An additional 196 volunteers were se-
lected as sea-level controls.
Subjects who agreed to participate in the study were
familiarized with the purposes and processes of this
study and signed informed consents before the trials.
The study was approved by the Ethics Committee of
Xinqiao Hospital, the Second Clinic Medical College of
Third Military Medical University.
The participants underwent routine blood tests after a
5 min rest using a BC-3000 plus automated hematology
corpuscle analyzer (Shenzhen, China). Structured case
report form (CRF) questionnaires were used to record
the demographic information and the symptoms of
AMS, including the following: headache (0 = withoutheadache; 1 = mild headache; 2 = moderate headache;
3 = severe headache), dizziness (0 = without dizziness;
1 = mild dizziness; 2 = moderate dizziness; 3 = severe
dizziness), gastrointestinal symptoms (0 = without and
1 = with gastrointestinal symptoms), insomnia (0 = as
well as usual; 1 = not so well as usual; 2 = wake up sev-
eral times over the night and 3 = difficult to sleep) and
fatigue (0 = without fatigue and 1 = with fatigue). AMS
was diagnosed by the Lake Louise self-assessment scor-
ing system (LLS) as individuals who arrived at high alti-
tude with headaches and an LLS score >3 [9].
Statistical analysis
The normally distributed measurement variables [age,
body mass index (BMI), [Hb], HCT, RBC, MCV, MCH
and MCHC] were expressed as mean ± standard devi-
ation (SD). These variables were employed by independ-
ent sample t tests between the AMS+ and AMS− groups
and were compared by ANOVA in the sea-level, 24-h,
7-d, acclimated and re-exposure groups. The relation-
ship between the AMS score and these parameters were
analyzed by Pearson’s correlation. The statistical analyses
were performed using SPSS 19.0 for Windows. P < 0.05
was considered to be statistically significant. Statisticians
from the Third Military Medical University were con-
sulted in regard to all of the statistical methods and
results.
Results
The CRFs were excluded if the demographic information
was incomplete. A total of 692 valid CRFs were ob-
tained. The ages and BMIs were matched among the five
groups (P = 0.151 and 0.471, respectively) (Table 1).
After exposure at 3,700 m, the [Hb] was elevated signifi-
cantly compared with that at sea level. The [Hb] increased
greatly after the subjects were re-exposed to an altitude
higher than 3,700 m. However, the RBC count fell slightly
but not significantly after acute exposure, although it in-
creased significantly when the subjects were re-exposed to
4,400 m from their acclimation altitude (3700 m) (Table 2).
The HCT was lower in the 24-h group than in the sea-
level control group (41.32 ± 3.29 vs. 42.71 ± 3.22 L/L,
Table 2 Descriptions of the [Hb], RBC, HCT, MCV, MCH and MCHC for each group
Group [Hb] (g/L) RBC (1012) HCT (L/L) MCV (fl) MCH (pg) MCHC (g/L)
Sea-level (n = 196) 141.30 ± 10.68 4.66 ± 0.59 42.71 ± 3.22 91.35 ± 7.81 30.37 ± 3.05 331.05 ± 13.78
24-h group (n = 261) 145.91 ± 12.94a 4.58 ± 0.39 41.32 ± 3.29a 90.44 ± 6.44 31.88 ± 2.30 352.39 ± 8.13a
7-d group (n = 99) 170.92 ± 11.78ac 5.15 ± 0.40ac 46.68 ± 3.11ac 91.01 ± 4.71 33.26 ± 2.12 365.77 ± 9.66ac
Acclimated group (n = 42) 168.02 ± 1.69 ac 5.06 ± 0.37ac 47.05 ± 3.25ac 93.12 ± 3.00b 33.19 ± 1.20ac 356.71 ± 6.01be
Re-exposure group (n = 94) 185.30 ± 11.53acef 5.72 ± 0.61acef 53.55 ± 5.84acef 93.74 ± 3.98ace 32.54 ± 2.40bd 347.63 ± 22.60acef
F value 312.573 112.052 213.735 5.803 30.192 144.797
P value# <0.001
#P values among the five groups. a. P < 0.01 compared with the sea level group; b. P < 0.05, c. P < 0.01 compared with the 24-h group; d. P < 0.05, e. P < 0.01
compared with the 7-d group; f. P < 0.01 compared with the acclimated group.
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exposure groups (46.68 ± 3.11 and 53.55 ± 5.84 L/L). How-
ever, the MCV was much higher in the re-exposure group
than in the other three groups. It is interesting that the re-
exposure group was characterized by a lower MCHC than
that in the 24-h, 7-d and acclimated groups (P = 0.003,
P < 0.001 and P < 0.001), although it was still greater than
in the control group (Table 2).
The incidence of AMS was 65.1%, 26.3% and 51.1% in
the 24-h, 7-d and re-exposure groups, respectively. Al-
though the subjects in the re-exposure group had been
acclimated for more than 1 year, the incidence of AMS
was still much higher when they were re-exposed to a
new altitude than when they were first exposed for the
same duration of time (χ2 = 12.545, P = 0.001). The inci-
dence of AMS was significantly different among a series
of spans that were divided by an interval of 20 g/L ac-
cording to the [Hb] means in each group. The baseline
level of the [Hb] increased with the duration of the
high-altitude exposure. Thus, the initial [Hb] was incon-
sistent in the three groups above. The incidences were
lowest when the [Hb] was between 140 and 160 g/L in
the 24 h and 7-d groups (Figure 1).
The [Hb], RBC, HCT, MCV, MCH and MCHC param-
eters of the hematological system were not statistically
significantly different between the AMS+ and AMS−
groups in either the 24-h group or the re-exposureFigure 1 Comparisons of AMS incidences in variant [Hb] spans amon
(b) 7-d group and (c) re-exposure group.group (P > 0.05). However, the [Hb] (P = 0.024) and
HCT (P = 0.017) were greater in the AMS+ individuals
than that in the AMS− ones seven days after their arrival
at 4,400 m (Table 3). The [Hb], RBC and HCT each had
a negative relationship with AMS score in the 24-h
group, but it was not significant for any of them. The
[Hb] (r = 0.198, P = 0.049) and HCT (r = 0.207, P = 0.039)
were significantly positively related with AMS score in
the 7-d group, and they were also correlated with AMS
score in the re-exposure group (r = 0.259, P = 0.012 and
r = 0.213, P = 0.040). In addition, the RBC count was also
closely associated with the AMS score in the latter group
(r = 0.239, P = 0.020) (Table 4).
Discussion
The hematological components related to the delivery of
oxygen were affected differently after high altitude expos-
ure. The [Hb] responded more rapidly to short-term hyp-
oxia than RBC in that it was related closely with AMS in
both the 7-d group and re-exposure group. The incidences
were lowest when the [Hb] was between 140 g/L and
160 g/L, which generally indicates an optimal [Hb] level.
Excessive erythrocytosis after high-altitude exposure
The [Hb] modified sharply after elevations to 3,700 m,
and it rose gradually along with increases in the duration
of the exposure, which was consistent with previousg the 24-h, 7-d and re-exposure groups. (a) 24 -h group,
Table 3 Differences in the [Hb], RBC, HCT, MCV, MCH and MCHC between the AMS+ and AMS− groups
24-h group 7-d group Re-exposure group
AMS+ (n = 190) AMS−(n = 71) t P AMS+ (n = 26) AMS−(n = 73) t P AMS+ (n = 48) AMS−(n = 46) t P
[Hb] (g/L) 145.77 ± 12.04 146.55 ± 15.24 −0.432 0.666 175.38 ± 10.82 169.33 ± 11.77 2.299 0.024* 187.06 ± 12.69 183.46 ± 9.99 −1.527 0.130
RBC (1012) 4.57 ± 0.39 4.62 ± 0.40 −0.990 0.323 5.23 ± 0.35 5.12 ± 0.41 1.225 0.223 5.81 ± 0.72 5.62 ± 0.45 −1.519 0.132
HCT (L/L) 41.29 ± 3.08 41.48 ± 3.83 −0.398 0.691 47.91 ± 2.69 46.24 ± 3.15 2.419 0.017* 54.34 ± 6.93 52.72 ± 4.36 −1.358 0.178
MCV (fl) 90.77 ± 5.48 89.58 ± 8.49 1.331 0.184 91.87 ± 2.81 90.71 ± 5.21 1.085 0.281 93.64 ± 4.30 93.86 ± 3.66 0.268 0.789
MCH (pg) 31.96 ± 2.19 31.70 ± 2.59 0.797 0.426 33.54 ± 1.23 33.16 ± 2.36 0.777 0.439 32.39 ± 2.66 32.69 ± 2.11 0.600 0.550




















Table 4 Relationships between the AMS score and the [Hb], RBC, HCT, MCV, MCH and MCHC
Index
24-h group 7-d group Re-exposure group
Pearson’s r value P value Pearson’s r value P value Pearson’s r value P value
[Hb] −0.065 0.297 0.198* 0.049 0.259* 0.012
RBC −0.076 0.222 0.192 0.057 0.239* 0.020
HCT −0.069 0.264 0.207* 0.039 0.213* 0.040
MCV 0.056 0.372 −0.015 0.885 −0.050 0.632
MCH 0.024 0.694 −0.018 0.859 −0.091 0.385
MCHC −0.027 0.667 −0.021 0.833 −0.064 0.538
*P < 0.05.
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more RBC in the blood after a longer duration of accli-
mation may be caused by the increased erythropoietin
(EPO) level that corresponds to hypobaric hypoxia in
such a chronic progressive process [4,14]. Thus, it can
be concluded that the alterations in Hb occur prior to
changes in the RBC. We also observed that the HCT
had a more extensive elevation in the 24-h group, while
the RBC count had a slight reduction, which would indi-
cate that the individuals had suffered transient hemodi-
lution upon acute high-altitude exposure, which was
conflicted with the view that acute pachyhemia occurs
upon exposure to high altitude. Nevertheless, the re-
exposure group had the highest RBC count, which was
in agreement with several studies on migration and na-
tives of high altitude [1,3,4,15].
There was no significant difference in the volume of the
RBC in the former three groups except that the increased
MCV in the re-exposure group showed a modification of
the RBC in the long-term hypoxia environment. Thus, the
augmentation of MCHC can be ascribed to the aug-
mented [Hb] combined with the unchanged MCV.The relationships between AMS and excessive
erythrocytosis
The conflicts among the alterations of Hb, HCT and
RBC may be potential mechanisms of AMS.
The [Hb], RBC, HCT, MCV, MCH and MCHC were
not significantly different between the AMS+ and AMS−
populations upon acute high altitude stress. However, in
the 7-d group, the [Hb] and HCT levels were higher in
the AMS+ individuals than that in the AMS− ones. We
have observed that the [Hb] and HCT were related to
the AMS scores in both the 7-d and re-exposure groups,
and the RBC count was also related to AMS in the latter
group. Those results revealed that the rapid response of
Hb and lengthier alteration in RBC would be critical
pathogenesis processes of AMS.
The alterations of [Hb], HCT and RBC alter the hemor-
heology and hemodynamics. One mechanism of AMS is
that the greater augmentations of HCT and RBC elevatethe viscosity of the blood and decrease the cardiac output,
which reduces the delivery of oxygen [2].
There was a novel interesting discovery that the RBC
count increased rapidly upon the subjects’ exposure to a
higher altitude. This observation reveals that long-term
hypoxia may condition the hematopoietic system to be
more sensitive to more extended hypoxia and that the
damage induced by hypoxia had already occurred. The
mechanisms of the above-mentioned phenomenon per-
haps are related to the over-expressed and augmented
EPO and EPO receptors resulting from persistent hyp-
oxia. These alterations in the EPO and EPO receptors
effectually enhance hematopoiesis, although the ery-
throcythemia had not yet emerged [14,16].Is there an optimal [Hb] for the prevention of AMS?
The elevations in the [Hb], RBC and HCT after migra-
tions to high altitude had been described decades ago
and were thought to be advantageous compensations
[3,5]. However, the benefits of excessively increased Hb,
RBC and HCT and even the pathological states, such as
high altitude polycythemia (HAPC), have been chal-
lenged by the side effects of the enhanced viscosity and
the slowed blood flow velocity and cardiac output
resulting in the decreased delivery of oxygen to the tis-
sues [12]. Additionally, there was also a theoretical con-
clusion that the optimal [Hb] for the human body for
adaption to high altitude is 147.0 g/L [12].
Although the optimal [Hb] has been demonstrated by
a theoretical study, few practical clinical investigations
have been performed to confirm the precise value of the
so-called optimal [Hb] [12].
In our current study, the lowest incidence of AMS fall
within the span of 140 to 160 g/L, which is consistent
with the theoretical approximate value of an optimal
[Hb] of 147.0 g/L [12]. Thus, the excessive increases in
the Hb and RBC are not entirely beneficial for the hu-
man body’s acclimation to high altitude. The influence
of the variations in the participants’ sizes on the inci-
dence of AMS cannot be overlooked in the re-exposure
group when the [Hb] was greater than 200 g/L.
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There were only young men in our study, which perhaps
induced an age and gender bias, which will be adjusted
in future studies.
Conclusions
The changes in the [Hb], HCT and RBC counts were not
isochronous after high-altitude exposures. Our observa-
tions indicate that AMS is associated with Hb and that ex-
cessive erythrocytosis may facilitate the pathogenesis of
AMS. Additionally, our findings indicate the existence of
an optimal [Hb] for preventing AMS.
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